WuXi AppTec
Director of In Vivo Oncology at WuXi Biology, serving as the scientific bridge between US clients and advanced technology platforms, providing deep expertise in oncology research and drug development.
WuXi AppTec is a global contract research, development and manufacturing organization (CRDMO) that provides integrated R&D and manufacturing services to pharmaceutical, biotech and medical device companies. Its offerings span discovery and preclinical research, clinical development support, analytical testing, and GMP manufacturing for small molecules, biologics, cell and gene therapies, and advanced therapeutics. With a worldwide network of labs and manufacturing facilities, WuXi positions itself as an end-to-end partner focused on accelerating drug development through scalable technology platforms, quality and regulatory expertise, and flexible outsourcing solutions.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for WuXi AppTec.
15% below the average for this role
Principal Scientist
Syngene International Limited
Scientist – In Vivo Pharmacology
lifelancer
Director/Senior Director, In Vivo Pharmacology
Rezo Therapeutics
Principal Scientist, Cancer Pharmacology, Translational Research
Revolution Medicines
Senior. Scientist, In Vivo Pharmacology
Merck & Co., Inc.
Translational Biologist
Isomorphic Labs